Search Results - "PLANAS, R." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO)

Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO)

by Buti, M., Calleja, J. L., Lens, S., Diago, M., Ortega, E., Crespo, J., Planas, R., Romero‐Gómez, M., Rodríguez, F. G., Pascasio, J. M., Fevery, B., Kurland, D., Corbett, C., Kalmeijer, R., Jessner, W.
Published in Alimentary pharmacology & therapeutics (01.02.2017)

Get full text

Journal Article

Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes

Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes

by Planas, R, Carrillo, J, Sanchez, A, Ruiz de Villa, M.C, Nuñez, F, Verdaguer, J, James, R.F.L, Pujol-Borrell, R, Vives-Pi, M
Published in Clinical and experimental immunology (01.01.2010)

Get full text

Journal Article

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

by Lucena, M.I, Kaplowitz, N, Hallal, H, Castiella, A, García-Bengoechea, M, Otazua, P, Berenguer, M, Fernandez, M.C, Planas, R, Andrade, R.J
Published in Journal of hepatology (01.10.2011)

Get full text

Journal Article

Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol

Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol

by Ortí-Asencio, M., Salinas-Huertas, S., Luzardo-González, A., Terra-Falótico, J., Planas-Balagué, R.
Published in Clinical & translational oncology (01.10.2021)

Get full text

Journal Article

Hepacontrol: A Program That Reduces Early Hospital Readmissions and Mortality among Patients with Decompensated Cirrhosis

Hepacontrol: A Program That Reduces Early Hospital Readmissions and Mortality among Patients with Decompensated Cirrhosis

by Morales Arrieta, B.P, Masnou, H, Bartoli, R, Morillas, R.M, Sala, M, Casas, I, Planas, R
Published in Journal of hepatology (2016)

Get full text

Journal Article

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

by Puigvehí, M, Londoño, M.-C, Morillas, R.M, Miquel, M, Gallego, A, Lens, S, Mariño, Z, Vergara, M, Lorente, S, Torras, X, Planas, R, Solà, R, Carrión, J.A
Published in Journal of hepatology (2017)

Get full text

Journal Article

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

by Marin-Gallen, S, Clemente-Casares, X, Planas, R, Pujol-Autonell, I, Carrascal, J, Carrillo, J, Ampudia, R, Verdaguer, J, Pujol-Borrell, R, Borràs, F.E, Vives-Pi, M
Published in Clinical and experimental immunology (01.05.2010)

Get full text

Journal Article

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis

by Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S
Published in Journal of hepatology (2016)

Get full text

Journal Article

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

by Puigvehí, M, Londoño, M.-C, Morillas, R.M, Miquel, M, Gallego, A, Lens, S, Mariño, Z, Vergara, M, Lorente, S, Torras, X, Planas, R, Solà, R, Carrión, J.A
Published in Journal of hepatology (2016)

Get full text

Journal Article

Simeprevir plus Sofosbuvir for Hepatitis C Virus Genotype 4 Infection: A Phase 3, Open-Label Study

Simeprevir plus Sofosbuvir for Hepatitis C Virus Genotype 4 Infection: A Phase 3, Open-Label Study

by Buti, M, Calleja, J.L, Forns, X, Diago, M, Ortega, E, Crespo, J, Planas, R, Fevery, B, Kurland, D, Buelens, A, Corbett, C, Kalmeijer, R, Jessner, W
Published in Journal of hepatology (2016)

Get full text

Journal Article

Endoscopist experience as a risk factor for colonoscopic complications

Endoscopist experience as a risk factor for colonoscopic complications

by Lorenzo-Zúñiga, V., Moreno de Vega, V., Doménech, E., Mañosa, M., Planas, R., Boix, J.
Published in Colorectal disease (01.10.2010)

Get full text

Journal Article

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

by Sanmartín, R, Tor, J, Sanvisens, A, López, JJ, Jou, A, Muga, R, Ojanguren, I, Barluenga, E, Videla, S, Planas, R, Clotet, B, Tural, C
Published in HIV medicine (01.04.2014)

Get full text

Journal Article

The Macrophage Protein CD5L Acts as a Pro-Oncogenic Factor in Hepatocytes

The Macrophage Protein CD5L Acts as a Pro-Oncogenic Factor in Hepatocytes

by Aran, G, Sanjurjo, L, Bárcena, C, Javid, M, Simon, M, Vázquez, M, Díaz, E, Huertas, C, Varela, M, Miquel, M, Coll, S, Ojanguren, I, Bartolí, R, Sala, M, Planas, R, Armengol, C, Sarrias, M.-R
Published in Journal of hepatology (2016)

Get full text

Journal Article

Comprehensive Proteomic Study of Hepatoblastoma: Identification of a Prognostic Signature and Deregulated Pathways

Comprehensive Proteomic Study of Hepatoblastoma: Identification of a Prognostic Signature and Deregulated Pathways

by Simon, M, Azkargorta, M, Guerra, L, Nonell, L, López-Santamaria, M, Garrido, M, Mateos, M.E, Belendez, C, Plaza, D, Hernandez, F, Mendiola, M, Ojanguren, I, Childs, M, Czauderna, P, Maibach, R, Morland, B, Buendia, M.A, Elortza, F, Planas, R, Sarrias, M.-R, Sala, M, Armengol, C
Published in Journal of hepatology (2016)

Get full text

Journal Article

De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C

De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C

by MARTÍN‐SANTOS, R., DÍEZ‐QUEVEDO, C., CASTELLVÍ, P., NAVINÉS, R., MIQUEL, M., MASNOU, H., SOLER, A., ARDEVOL, M., GARCÍA, F., GALERAS, J. A., PLANAS, R., SOLÀ, R.
Published in Alimentary pharmacology & therapeutics (01.02.2008)

Get full text

Journal Article

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C

by Romero‐Gómez, M., Planas, R., Ampuero, J., Solà, R., García‐Samaniego, J., Diago, M., Crespo, J., Calleja, J. L., Turnes, J.
Published in Alimentary pharmacology & therapeutics (01.06.2013)

Get full text

Journal Article

P1201 UTILITY OF SERUM MARKERS AND TRANSIENT ELASTOGRAPHY TO IDENTIFY SERIOUS ADVERSE EFFECTS DURING ANTIVIRAL THERAPY IN HCV INFECTED CIRRHOTIC PATIENTS. A MULTICENTER STUDY

P1201 UTILITY OF SERUM MARKERS AND TRANSIENT ELASTOGRAPHY TO IDENTIFY SERIOUS ADVERSE EFFECTS DURING ANTIVIRAL THERAPY IN HCV INFECTED CIRRHOTIC PATIENTS. A MULTICENTER STUDY

by Puigvehí, M, Londoño, M.C, Morillas, R.M, Miquel, M, Gallego, A, Lens, S, Baiges, A, Vergara, M, Torras, X, Planas, R, Solà, R, Carrión, J.A
Published in Journal of hepatology (01.04.2014)

Get full text

Journal Article

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN

by Ferenci, P, Nyberg, A, Enayati, P, Bernstein, D, Baruch, Y, Caruntu, F.A, Chulanov, V, Janczewska, E, Younes, Z, Marinho, R.T, Rizzardini, G, Gervain, J, Planas, R, Moreno, C, Xie, W, Cohen, D, King, M, Podsadecki, T, Reddy, K.R
Published in Journal of hepatology (01.04.2014)

Get full text

Journal Article

Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry

Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry

by García-Cortés, M, Borraz, Y, Lucena, M I, Peláez, G, Salmerón, J, Diago, M, Martínez-Sierra, M C, Navarro, J M, Planas, R, Soria, M J, Bruguera, M, Andrade, R J
Published in Revista española de enfermedades digestivas (01.11.2008)

Get full text

Journal Article

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β

by Alba, A, Planas, R, Clemente, X, Carrillo, J, Ampudia, R, Puertas, M.-C, Pastor, X, Tolosa, E, Pujol-Borrell, R, Verdaguer, J, Vives-Pi, M
Published in Clinical and experimental immunology (01.03.2008)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[17]